Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

63.81USD
20 Apr 2018
Change (% chg)

$-1.20 (-1.85%)
Prev Close
$65.01
Open
$64.84
Day's High
$65.46
Day's Low
$63.70
Volume
12,676
Avg. Vol
48,116
52-wk High
$68.98
52-wk Low
$21.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.28 -0.925
Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.41 1.14 0.00 1.23
Quarter Ending Sep-18 4 0.41 1.14 0.00 1.23
Year Ending Dec-18 6 3.16 10.00 0.80 4.29
Year Ending Dec-19 5 2.73 10.00 0.00 4.17
Earnings (per share)
Quarter Ending Jun-18 4 -0.75 -0.58 -0.81 -0.44
Quarter Ending Sep-18 4 -0.75 -0.58 -0.81 -0.44
Year Ending Dec-18 6 -3.14 -2.35 -3.45 -2.71
Year Ending Dec-19 5 -3.21 -1.72 -4.05 -4.15
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.22 33.60
P/E High - Last 5 Yrs. -- 284.72 45.95
P/E Low - Last 5 Yrs. -- 95.76 24.93
Beta -- 0.75 0.80
Price to Sales (TTM) 1,409.55 136.15 7.07
Price to Book (MRQ) 10.26 19.54 5.13
Price to Tangible Book (MRQ) 11.74 24.07 6.73
Price to Cash Flow (TTM) -- 122.99 25.52
% Owned Institutions 74.76 11.18 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.94 3.93
Payout Ratio(TTM) -- 9.18 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -73.15 103.73 9.02
Sales (TTM) vs TTM 1 Yr. Ago -66.78 79.72 10.83
Sales - 5 Yr. Growth Rate -37.14 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -72.90 -66.87 22.25
EPS (TTM) vs TTM 1 Yr. Ago -41.48 -- --
EPS - 5 Yr. Growth Rate -- 47.46 10.26
Capital Spending - 5 Yr. Growth Rate 26.46 45.48 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 8.61 5.97 3.62
LT Debt to Equity (MRQ) 0.00 23.32 11.31
Total Debt to Equity (MRQ) 0.00 25.75 13.97
Interest Coverage (TTM) -- -186.61 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.56 54.01
Gross Margin - 5 Yr. Avg. -- 55.38 52.12
EBITD Margin (TTM) -7,242.29 -- --
EBITD - 5 Yr. Avg -473.06 -152.18 15.89
Operating Margin (TTM) -7,290.26 -563.03 4.33
Operating Margin - 5 Yr. Avg. -478.97 -164.18 11.25
Pre-Tax Margin (TTM) -8,129.02 -535.84 4.97
Pre-Tax Margin - 5 Yr. Avg. -477.57 -171.12 11.56
Net Profit Margin (TTM) -8,097.84 -524.81 1.58
Net Profit Margin - 5 Yr. Avg. -474.67 -171.01 7.89
Effective Tax Rate (TTM) -- -0.44 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 13,721 23,887,722 816,988,634
Net Income/Employee (TTM) -1,111,100 956,935 96,050,323
Receivable Turnover (TTM) 6.44 6.24 5.56
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.01 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.79 -0.77 10.54
Return on Assets - 5 Yr. Avg. -43.95 0.70 11.56
Return on Investment (TTM) -68.11 -0.74 13.19
Return on Investment - 5 Yr. Avg. -52.07 4.20 14.97
Return on Equity (TTM) -68.11 -2.80 15.00
Return on Equity - 5 Yr. Avg. -52.07 -0.05 16.25
  1 Year 3 Year 5 Year
Sales % -66.78 -52.17 -37.14
EPS (TTM) % -42.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.79 -3.84 47 9
13 Week 23.83 30.33 85 72
26 Week 81.95 75.48 91 89
52 Week 130.61 103.47 91 77
YTD 59.29 59.49 89 88
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.79%
# of Holders: 82
Total Shares Held: 31,097,172
3 Mo. Net Change: 400,392
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 5
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.